Oviva, which provides a tech-based approach for Type 2 diabetes treatment in Europe, raises $21M Series B led by MTIP, bringing its total raised to $34M (Steve O’Hear/TechCrunch)


Steve O’Hear / TechCrunch:

Oviva, which provides a tech-based approach for Type 2 diabetes treatment in Europe, raises $21M Series B led by MTIP, bringing its total raised to $34M  —  Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?